Skip to main content
Top
Published in: Current Reviews in Musculoskeletal Medicine 3/2018

01-09-2018 | Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

The Role of One-Stage Exchange for Prosthetic Joint Infection

Authors: Fiachra E. Rowan, Matthew J. Donaldson, Jurek R. Pietrzak, Fares S. Haddad

Published in: Current Reviews in Musculoskeletal Medicine | Issue 3/2018

Login to get access

Abstract

Purpose of Review

In an era of increasing numbers of hip and knee replacements, strategies to manage prosthetic joint infection (PJI) that are effective at infection control with good patient-reported outcomes and cost containment for health systems are needed. Interest in single-stage exchange for PJI is rising and we assess evidence from the last 5 years related to this treatment strategy.

Recent Findings

Only five series for total knee replacement and ten series for total hip replacement have been reported in the last five years. More review articles and opinion pieces have been written. Reinfection rates in these recent studies range from 0 to 65%, but a meta-analysis and systematic review of all studies showed a reinfection rate of 7.6% (95% CI 3.4–13.1) and 8.8% (95% CI 7.2–10.6) for single-stage and two-stage revisions respectively. There is emerging evidence to support single-stage revision in the setting of significant bony deficiency and atypical PJIs such as fungal infections.

Summary

Prospective randomised studies are recruiting and are necessary to guide the direction of single-stage revision selection criteria. The onus of surgical excellence in mechanical removal of implants, necrotic tissue, and biofilms lies with the arthroplasty surgeon and must remain the cornerstone of treatment. Single-stage revision may be considered the first-line treatment for all PJIs unless the organism is unknown, the patient is systemically septic, or there is a poor tissue envelope.
Literature
1.
go back to reference Culliford D, Maskell J, Judge a, Cooper C, Prieto-Alhambra D, Arden NK. Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink. Osteoarthr Cartil Elsevier Ltd. 2015;23:594–600.CrossRef Culliford D, Maskell J, Judge a, Cooper C, Prieto-Alhambra D, Arden NK. Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink. Osteoarthr Cartil Elsevier Ltd. 2015;23:594–600.CrossRef
2.
go back to reference Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467:2606–12.CrossRefPubMedPubMedCentral Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467:2606–12.CrossRefPubMedPubMedCentral
3.
go back to reference Kumar A, Tsai W-C, Tan T-S, Kung P-T, Chiu L-T, Ku M-C. Temporal trends in primary and revision total knee and hip replacement in Taiwan. J Chinese Med Assoc. 2015;78:538–44.CrossRef Kumar A, Tsai W-C, Tan T-S, Kung P-T, Chiu L-T, Ku M-C. Temporal trends in primary and revision total knee and hip replacement in Taiwan. J Chinese Med Assoc. 2015;78:538–44.CrossRef
4.
go back to reference Kurtz SM, Ong KL, Lau E, Widmer M, Maravic M, Gómez-Barrena E, et al. International survey of primary and revision total knee replacement. Int Orthop Springer. 2011;35:1783–9. Kurtz SM, Ong KL, Lau E, Widmer M, Maravic M, Gómez-Barrena E, et al. International survey of primary and revision total knee replacement. Int Orthop Springer. 2011;35:1783–9.
5.
go back to reference Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–5.PubMed Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–5.PubMed
6.
go back to reference Learmonth ID, Young C, Rorabeck C, Bs B. The operation of the century: total hip replacement. 2007;370. Learmonth ID, Young C, Rorabeck C, Bs B. The operation of the century: total hip replacement. 2007;370.
7.
go back to reference Skou ST, Roos EM, Laursen MB, Rathleff MS, Arendt-Nielsen L, Simonsen O, et al. A randomized, controlled trial of total knee replacement. N Engl J Med. 2015;373:1597–606. Skou ST, Roos EM, Laursen MB, Rathleff MS, Arendt-Nielsen L, Simonsen O, et al. A randomized, controlled trial of total knee replacement. N Engl J Med. 2015;373:1597–606.
8.
go back to reference Gundtoft PH, Overgaard S, Schønheyder HC, Møller JK, Kjærsgaard-Andersen P, Pedersen AB. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop Taylor & Francis. 2015;86:326–34.CrossRef Gundtoft PH, Overgaard S, Schønheyder HC, Møller JK, Kjærsgaard-Andersen P, Pedersen AB. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop Taylor & Francis. 2015;86:326–34.CrossRef
9.
go back to reference Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466:1710–5.CrossRefPubMedPubMedCentral Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466:1710–5.CrossRefPubMedPubMedCentral
10.
go back to reference Haddad FS. Even the winners are losers. Bone Joint J Br Editorial Soc Bone Joint Surg; 2017;99–B:561–562. Haddad FS. Even the winners are losers. Bone Joint J Br Editorial Soc Bone Joint Surg; 2017;99–B:561–562.
11.
go back to reference Marang-van de Mheen PJ, Bragan Turner E, Liew S, Mutalima N, Tran T, Rasmussen S, et al. Variation in prosthetic joint infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals. BMC Musculoskelet Disord BioMed Central. 2017;18:207.CrossRef Marang-van de Mheen PJ, Bragan Turner E, Liew S, Mutalima N, Tran T, Rasmussen S, et al. Variation in prosthetic joint infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals. BMC Musculoskelet Disord BioMed Central. 2017;18:207.CrossRef
12.
go back to reference Werner BC, Higgins MD, Pehlivan HC, Carothers JT, Browne JA. Super obesity is an independent risk factor for complications after primary total hip arthroplasty. J Arthroplast. 2017;32:402–6.CrossRef Werner BC, Higgins MD, Pehlivan HC, Carothers JT, Browne JA. Super obesity is an independent risk factor for complications after primary total hip arthroplasty. J Arthroplast. 2017;32:402–6.CrossRef
13.
go back to reference Grant JA, Viens N, Bolognesi MP, Olson SA, Cook CE. Two-year outcomes in primary THA in obese male veterans administration medical center patients. Rheumatol Int. 2008;28:1105–9.CrossRefPubMed Grant JA, Viens N, Bolognesi MP, Olson SA, Cook CE. Two-year outcomes in primary THA in obese male veterans administration medical center patients. Rheumatol Int. 2008;28:1105–9.CrossRefPubMed
14.
go back to reference Wagner ER, Kamath AF, Fruth KM, Harmsen WS, Berry DJ. Effect of body mass index on complications and reoperations after Total hip arthroplasty. J Bone Jt Surg. 2016;98:169–79.CrossRef Wagner ER, Kamath AF, Fruth KM, Harmsen WS, Berry DJ. Effect of body mass index on complications and reoperations after Total hip arthroplasty. J Bone Jt Surg. 2016;98:169–79.CrossRef
15.
16.
go back to reference Kallala RF, Vanhegan IS, Ibrahim MS, Sarmah S, Haddad FS. Financial analysis of revision knee surgery based on NHS tariffs and hospital costs: does it pay to provide a revision service? Bone Joint J. 2015;97–B:197–201.CrossRefPubMed Kallala RF, Vanhegan IS, Ibrahim MS, Sarmah S, Haddad FS. Financial analysis of revision knee surgery based on NHS tariffs and hospital costs: does it pay to provide a revision service? Bone Joint J. 2015;97–B:197–201.CrossRefPubMed
17.
go back to reference Kamath AF, Ong KL, Lau E, Chan V, Vail TP, Rubash HE, et al. Quantifying the burden of revision total joint arthroplasty for periprosthetic infection. J Arthroplast. 2015;30:1492–7. Kamath AF, Ong KL, Lau E, Chan V, Vail TP, Rubash HE, et al. Quantifying the burden of revision total joint arthroplasty for periprosthetic infection. J Arthroplast. 2015;30:1492–7.
18.
go back to reference Klouche S, Sariali E, Mamoudy P. Analyse du coût des reprises des prothèses totales de hanche infectées. Rev Chir Orthopédique Traumatol. 2010;96:167–75.CrossRef Klouche S, Sariali E, Mamoudy P. Analyse du coût des reprises des prothèses totales de hanche infectées. Rev Chir Orthopédique Traumatol. 2010;96:167–75.CrossRef
19.
go back to reference Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious Diseases Society of America. Clin Infect Dis. 2013;56:1–10. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious Diseases Society of America. Clin Infect Dis. 2013;56:1–10.
20.
go back to reference Carlsson AS, Josefsson G, Lindberg L. Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg Am. 1978;60:1059–64.CrossRefPubMed Carlsson AS, Josefsson G, Lindberg L. Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg Am. 1978;60:1059–64.CrossRefPubMed
21.
go back to reference Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Jt Surgery, Br. 1981;63-B:342–53.CrossRef Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Jt Surgery, Br. 1981;63-B:342–53.CrossRef
22.
go back to reference Jones LC, Hungerford DS. Cement disease. Clin Orthop Relat Res. 1987:192–206. Jones LC, Hungerford DS. Cement disease. Clin Orthop Relat Res. 1987:192–206.
23.
go back to reference •• Kunutsor SK, Whitehouse MR, Lenguerrand E, Blom AW, Beswick AD, INFORM Team I. Re-infection outcomes following one- and two-stage surgical revision of infected knee prosthesis: a systematic review and meta-analysis. PLoS One Public Library of Science. 2016;11:e0151537. Reinfection rates from ten one-stage studies (423 participants) and 108 two-stage studies (5129 participants) were meta-analysed using random-effect models after arcsine transformation. The rate (95% confidence intervals) of reinfection was 7.6% (3.4–13.1) in one-stage studies. The corresponding reinfection rate for two-stage revision was 8.8% (7.2–10.6). Post-operative clinical outcomes of knee scores and range of motion were similar for both revision strategies. Available evidence from aggregate published data suggests that the one-stage revision strategy may be as effective as the two-stage revision strategy in treating infected knee prostheses in generally unselected patients CrossRef •• Kunutsor SK, Whitehouse MR, Lenguerrand E, Blom AW, Beswick AD, INFORM Team I. Re-infection outcomes following one- and two-stage surgical revision of infected knee prosthesis: a systematic review and meta-analysis. PLoS One Public Library of Science. 2016;11:e0151537. Reinfection rates from ten one-stage studies (423 participants) and 108 two-stage studies (5129 participants) were meta-analysed using random-effect models after arcsine transformation. The rate (95% confidence intervals) of reinfection was 7.6% (3.4–13.1) in one-stage studies. The corresponding reinfection rate for two-stage revision was 8.8% (7.2–10.6). Post-operative clinical outcomes of knee scores and range of motion were similar for both revision strategies. Available evidence from aggregate published data suggests that the one-stage revision strategy may be as effective as the two-stage revision strategy in treating infected knee prostheses in generally unselected patients CrossRef
24.
go back to reference Parvizi J, Gehrke T. Definition of periprosthetic joint infection. J Arthroplast. 2014;29:1331.CrossRef Parvizi J, Gehrke T. Definition of periprosthetic joint infection. J Arthroplast. 2014;29:1331.CrossRef
25.
go back to reference McPherson EJ, Woodson C, Holtom P, Roidis N, Shufelt C, Patzakis M. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res. 2002;403:8–15.CrossRef McPherson EJ, Woodson C, Holtom P, Roidis N, Shufelt C, Patzakis M. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res. 2002;403:8–15.CrossRef
26.
go back to reference George DA, Eng M, Haddad FS, Orth M, Orth F. One-stage exchange arthroplasty: a surgical technique update. J Arthroplasty Elsevier Ltd. 2017;32:S59–62.CrossRef George DA, Eng M, Haddad FS, Orth M, Orth F. One-stage exchange arthroplasty: a surgical technique update. J Arthroplasty Elsevier Ltd. 2017;32:S59–62.CrossRef
27.
go back to reference Kendoff D, Gehrke T. One stage exchange arthroplasty: the devil is in the detail. J. Bone Jt. Surg. 2012:1–6. Kendoff D, Gehrke T. One stage exchange arthroplasty: the devil is in the detail. J. Bone Jt. Surg. 2012:1–6.
28.
go back to reference Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Jt Surg - Br. 2008;90-B:1580–4.CrossRef Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Jt Surg - Br. 2008;90-B:1580–4.CrossRef
29.
go back to reference • Ilchmann T, Zimmerli W, Ochsner PE, Kessler B, Zwicky L, Graber P, Clauss M One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips. Int. Orthop. Int Orthop; 2016. 40, 913–918 Thirty-eight patients (39 hips) were treated with a one-stage procedure and followed for at least 2 years. In 25 hips, an uncemented revision stem was implanted, and 37 hips received an acetabular reinforcement ring. The mean follow-up was 6.6 (2.0–15.1) years. No patient had persistent, recurrent, or new infection. There were four stem revisions for aseptic loosening. Excellent cure rate and function seen in this study suggest that one-stage exchange is a safe procedure, even without local antibiotic treatment. • Ilchmann T, Zimmerli W, Ochsner PE, Kessler B, Zwicky L, Graber P, Clauss M One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips. Int. Orthop. Int Orthop; 2016. 40, 913–918 Thirty-eight patients (39 hips) were treated with a one-stage procedure and followed for at least 2 years. In 25 hips, an uncemented revision stem was implanted, and 37 hips received an acetabular reinforcement ring. The mean follow-up was 6.6 (2.0–15.1) years. No patient had persistent, recurrent, or new infection. There were four stem revisions for aseptic loosening. Excellent cure rate and function seen in this study suggest that one-stage exchange is a safe procedure, even without local antibiotic treatment.
30.
go back to reference Hansen E, Tetreault M, Zmistowski B, Della Valle CJ, Parvizi J, Haddad FS, et al. Outcome of one-stage cementless exchange for acute postoperative periprosthetic hip infection. Clin Orthop Relat Res. 2013;471:3214–22. Hansen E, Tetreault M, Zmistowski B, Della Valle CJ, Parvizi J, Haddad FS, et al. Outcome of one-stage cementless exchange for acute postoperative periprosthetic hip infection. Clin Orthop Relat Res. 2013;471:3214–22.
31.
go back to reference Negus JJ, Gifford PB, Haddad FS, Tr F. Single-stage revision arthroplasty for infection d an underutilized treatment strategy. J. Arthroplasty. Elsevier Ltd. 2017;32:2051–5.CrossRef Negus JJ, Gifford PB, Haddad FS, Tr F. Single-stage revision arthroplasty for infection d an underutilized treatment strategy. J. Arthroplasty. Elsevier Ltd. 2017;32:2051–5.CrossRef
32.
go back to reference McPherson EJ, Dipane MV, Sherif SM. Dissolvable antibiotic beads in treatment of periprosthetic joint infection and revision arthroplasty—the use of synthetic pure calcium sulfate (Stimulan®) impregnated with vancomycin & tobramycin. Reconstr Rev. 2013;3:32–43. McPherson EJ, Dipane MV, Sherif SM. Dissolvable antibiotic beads in treatment of periprosthetic joint infection and revision arthroplasty—the use of synthetic pure calcium sulfate (Stimulan®) impregnated with vancomycin & tobramycin. Reconstr Rev. 2013;3:32–43.
33.
go back to reference Wolf CF, Gu NY, Doctor JN, Manner PA, Leopold SS. Comparison of one and two-stage revision of total hip arthroplasty complicated by infection. J Bone Jt Surgery-American. 2011;93:631–9.CrossRef Wolf CF, Gu NY, Doctor JN, Manner PA, Leopold SS. Comparison of one and two-stage revision of total hip arthroplasty complicated by infection. J Bone Jt Surgery-American. 2011;93:631–9.CrossRef
34.
go back to reference Parkinson RW, Kay PR, Rawal A. A case for one-stage revision in infected total knee arthroplasty?. Knee Elsevier BV; 2011;18:1–4. Parkinson RW, Kay PR, Rawal A. A case for one-stage revision in infected total knee arthroplasty?. Knee Elsevier BV; 2011;18:1–4.
35.
go back to reference Haddad FS, Sukeik M, Alazzawi S. Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections? Clin Orthop Relat Res. 2015;473:8–14.CrossRefPubMed Haddad FS, Sukeik M, Alazzawi S. Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections? Clin Orthop Relat Res. 2015;473:8–14.CrossRefPubMed
36.
go back to reference Choi H, Kwon Y, Freiberg AA, Malchau H. Comparison of one-stage revision with antibiotic cement versus two-stage revision results for infected total hip arthroplasty. J. Arthroplasty. Elsevier Inc. 2013;28:66–70.CrossRef Choi H, Kwon Y, Freiberg AA, Malchau H. Comparison of one-stage revision with antibiotic cement versus two-stage revision results for infected total hip arthroplasty. J. Arthroplasty. Elsevier Inc. 2013;28:66–70.CrossRef
37.
go back to reference Baker P, Petheram TG, Kurtz S, Konttinen YT, Gregg P, Deehan D. Patient reported outcome measures after revision of the infected TKR: comparison of single versus two-stage revision. Knee Surgery, Sport Traumatol Arthrosc. 2013;21:2713–20.CrossRef Baker P, Petheram TG, Kurtz S, Konttinen YT, Gregg P, Deehan D. Patient reported outcome measures after revision of the infected TKR: comparison of single versus two-stage revision. Knee Surgery, Sport Traumatol Arthrosc. 2013;21:2713–20.CrossRef
38.
go back to reference Berend KR, Lombardi AV, Morris MJ, Bergeson AG, Adams JB, Sneller MA. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res. 2013;471:510–8.CrossRefPubMed Berend KR, Lombardi AV, Morris MJ, Bergeson AG, Adams JB, Sneller MA. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res. 2013;471:510–8.CrossRefPubMed
39.
go back to reference Klouche S, Leonard P, Zeller V, Lhotellier L, Graff W, Leclerc P, et al. Infected total hip arthroplasty revision: one- or two-stage procedure? Orthop Traumatol Surg Res Elsevier Masson SAS. 2012;98:144–50. Klouche S, Leonard P, Zeller V, Lhotellier L, Graff W, Leclerc P, et al. Infected total hip arthroplasty revision: one- or two-stage procedure? Orthop Traumatol Surg Res Elsevier Masson SAS. 2012;98:144–50.
40.
41.
go back to reference Gehrke T, Zahar A, Kendoff D. One-stage exchange: it all began here. Bone Joint J. 2013;95(B):77–83.CrossRefPubMed Gehrke T, Zahar A, Kendoff D. One-stage exchange: it all began here. Bone Joint J. 2013;95(B):77–83.CrossRefPubMed
42.
go back to reference Lichstein P, Gehrke T, Lombardi A, Romano C, Stockley I, Babis G, et al. One-stage versus two-stage exchange. J Orthop Res. 2014;32 Lichstein P, Gehrke T, Lombardi A, Romano C, Stockley I, Babis G, et al. One-stage versus two-stage exchange. J Orthop Res. 2014;32
43.
go back to reference Hughes PW, Salvati EA, Wilson PDJ, Blumenfeld EL. Treatment of subacute sepsis of the hip by antibiotics and joint replacement. Criteria for diagnosis with evaluation of twenty-six cases. Clin Orthop Relat Res. 1979:143–57. Hughes PW, Salvati EA, Wilson PDJ, Blumenfeld EL. Treatment of subacute sepsis of the hip by antibiotics and joint replacement. Criteria for diagnosis with evaluation of twenty-six cases. Clin Orthop Relat Res. 1979:143–57.
44.
go back to reference Miley GB, Scheller AD, Turner RH. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop Relat Res. 1982;(170):76. Miley GB, Scheller AD, Turner RH. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop Relat Res. 1982;(170):76.
45.
go back to reference Weber FA, Lautenbach EE. Revision of infected total hip arthroplasty. Clin Orthop Relat Res. 1986:108–15. Weber FA, Lautenbach EE. Revision of infected total hip arthroplasty. Clin Orthop Relat Res. 1986:108–15.
46.
go back to reference Wroblewski BM. One-stage revision of infected cemented total hip arthroplasty. Clin Orthop Relat Res. 1986:103–7. Wroblewski BM. One-stage revision of infected cemented total hip arthroplasty. Clin Orthop Relat Res. 1986:103–7.
47.
go back to reference Sanzén L, Carlsson AS, Josefsson G, Lindberg LT. Revision operations on infected total hip arthroplasties. Two- to nine-year follow-up study. Clin Orthop Relat Res 1988. p. 165–72. Sanzén L, Carlsson AS, Josefsson G, Lindberg LT. Revision operations on infected total hip arthroplasties. Two- to nine-year follow-up study. Clin Orthop Relat Res 1988. p. 165–72.
48.
go back to reference Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br. 1989;71:851–5.CrossRefPubMed Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br. 1989;71:851–5.CrossRefPubMed
49.
go back to reference Raut VV, Siney PD, Wroblewski BM. One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br. 1994;76:721–4.CrossRefPubMed Raut VV, Siney PD, Wroblewski BM. One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br. 1994;76:721–4.CrossRefPubMed
50.
go back to reference Mulcahy DM, O’Byrne JM, Fenelon GE. One stage surgical management of deep infection of total hip arthroplasty. Ir J Med Sci. 1996;165:17–9.CrossRefPubMed Mulcahy DM, O’Byrne JM, Fenelon GE. One stage surgical management of deep infection of total hip arthroplasty. Ir J Med Sci. 1996;165:17–9.CrossRefPubMed
51.
go back to reference Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am. 1998;80:961–8.CrossRefPubMed Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am. 1998;80:961–8.CrossRefPubMed
52.
go back to reference Callaghan JJ, Katz RP, Johnston RC. One-stage revision surgery of the infected hip. A minimum 10-year followup study. Clin Orthop Relat Res. 1999;369:139–43.CrossRef Callaghan JJ, Katz RP, Johnston RC. One-stage revision surgery of the infected hip. A minimum 10-year followup study. Clin Orthop Relat Res. 1999;369:139–43.CrossRef
53.
go back to reference Rudelli S, Uip D, Honda E, Lima ALLM. One-stage revision of infected total hip arthroplasty with bone graft. J Arthroplasty Elsevier BV. 2008;23:1165–77.CrossRef Rudelli S, Uip D, Honda E, Lima ALLM. One-stage revision of infected total hip arthroplasty with bone graft. J Arthroplasty Elsevier BV. 2008;23:1165–77.CrossRef
54.
go back to reference Matsen Ko LJ, Pollag KE, Yoo JY, Sharkey PF. Serum metal ion levels following total hip arthroplasty with modular dual mobility components. J Arthroplast. 2016;31:186–9.CrossRef Matsen Ko LJ, Pollag KE, Yoo JY, Sharkey PF. Serum metal ion levels following total hip arthroplasty with modular dual mobility components. J Arthroplast. 2016;31:186–9.CrossRef
55.
go back to reference Oussedik SIS, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Jt Surg - Br. 2010;92-B:1222–6.CrossRef Oussedik SIS, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Jt Surg - Br. 2010;92-B:1222–6.CrossRef
56.
go back to reference De Man FHR, Sendi P, Zimmerli W, Maurer TB, Ochsner PE, Ilchmann T. Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm. Acta Orthop. 2011;82:27–34.CrossRefPubMedPubMedCentral De Man FHR, Sendi P, Zimmerli W, Maurer TB, Ochsner PE, Ilchmann T. Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm. Acta Orthop. 2011;82:27–34.CrossRefPubMedPubMedCentral
57.
go back to reference Bori G, Muñoz-mahamud E, Cuñé J, Gallart X, Fuster D, Soriano A. One-stage revision arthroplasty using cementless stem for infected hip arthroplasties. J Arthroplasty Elsevier Inc. 2014;29:1076–81.CrossRef Bori G, Muñoz-mahamud E, Cuñé J, Gallart X, Fuster D, Soriano A. One-stage revision arthroplasty using cementless stem for infected hip arthroplasties. J Arthroplasty Elsevier Inc. 2014;29:1076–81.CrossRef
58.
go back to reference Jenny J, Lengert R, Diesinger Y. Routine one-stage exchange for chronic infection after total hip replacement. 2014;2477–81. Jenny J, Lengert R, Diesinger Y. Routine one-stage exchange for chronic infection after total hip replacement. 2014;2477–81.
59.
go back to reference Kamath AF, Rueger JM, Gebauer M, Gehrke T. Single-stage revision for fungal peri-prosthetic joint infection 2011;492–6. Kamath AF, Rueger JM, Gebauer M, Gehrke T. Single-stage revision for fungal peri-prosthetic joint infection 2011;492–6.
60.
go back to reference Wolf M, Clar H, Friesenbichler J, Schwantzer G, Bernhardt G, Gruber G, et al. Prosthetic joint infection following total hip replacement: results of one-stage versus two-stage exchange. Int Orthop. 2014;38:1363–8. Wolf M, Clar H, Friesenbichler J, Schwantzer G, Bernhardt G, Gruber G, et al. Prosthetic joint infection following total hip replacement: results of one-stage versus two-stage exchange. Int Orthop. 2014;38:1363–8.
61.
go back to reference Zeller V, Lhotellier L, Marmor S, Leclerc P, Krain A, Graff W, et al. One-stage exchange arthroplasty for chronic periprosthetic hip infection: results of a large prospective cohort study. J Bone Joint Surg Am. 2014;96:e1–1-9. Zeller V, Lhotellier L, Marmor S, Leclerc P, Krain A, Graff W, et al. One-stage exchange arthroplasty for chronic periprosthetic hip infection: results of a large prospective cohort study. J Bone Joint Surg Am. 2014;96:e1–1-9.
62.
go back to reference Ebied AM, Elseedy AI, Gamal O. Single-stage revision for periprosthetic hip infection using antibiotic loaded impaction graft. Hip Int. 2016;26:573–9.CrossRefPubMed Ebied AM, Elseedy AI, Gamal O. Single-stage revision for periprosthetic hip infection using antibiotic loaded impaction graft. Hip Int. 2016;26:573–9.CrossRefPubMed
63.
go back to reference Freeman M, Sudlow R, Casewell M, Radcliff S. The management of infected total knee replacements. J Bone Jt Surg. 1985;67:764–8.CrossRef Freeman M, Sudlow R, Casewell M, Radcliff S. The management of infected total knee replacements. J Bone Jt Surg. 1985;67:764–8.CrossRef
64.
go back to reference Göksan SB, Freeman MAR. One-stage reimplantation total for infected total knee arthroplasty. J. Bone Jt. Surg. 1992;74:78–82.CrossRef Göksan SB, Freeman MAR. One-stage reimplantation total for infected total knee arthroplasty. J. Bone Jt. Surg. 1992;74:78–82.CrossRef
65.
go back to reference Scott I. Exchange replacements. jbjs Br. 1993;75–B:28–31. Scott I. Exchange replacements. jbjs Br. 1993;75–B:28–31.
66.
go back to reference Silva M, Tharani R, Schmalzried TP. Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res. 2002;404:125–31.CrossRef Silva M, Tharani R, Schmalzried TP. Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res. 2002;404:125–31.CrossRef
67.
go back to reference Buechel FF, Femino FP, D’Alessio J. Primary exchange revision arthroplasty for infected total knee replacement: a long-term study. Am J Orthop (Belle Mead. NJ). 2004;33:190–8. discussion 198 Buechel FF, Femino FP, D’Alessio J. Primary exchange revision arthroplasty for infected total knee replacement: a long-term study. Am J Orthop (Belle Mead. NJ). 2004;33:190–8. discussion 198
68.
go back to reference Whiteside LA, Peppers M, Nayfeh TA, Roy ME. Methicillin-resistant staphylococcus aureus in TKA treated with revision and direct intraarticular antibiotic infusion. Clin Orthop Relat Res. 2011;469:26–33.CrossRefPubMed Whiteside LA, Peppers M, Nayfeh TA, Roy ME. Methicillin-resistant staphylococcus aureus in TKA treated with revision and direct intraarticular antibiotic infusion. Clin Orthop Relat Res. 2011;469:26–33.CrossRefPubMed
69.
go back to reference Singer J, Merz A, Frommelt L, Fink B. High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE. Clin Orthop Relat Res. 2012;470:1461–71.CrossRefPubMed Singer J, Merz A, Frommelt L, Fink B. High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE. Clin Orthop Relat Res. 2012;470:1461–71.CrossRefPubMed
70.
go back to reference Tibrewal S, Malagelada F, Jeyaseelan L, Posch F, Scott G. Single-stage revision for the infected total knee replacement: results from a single centre. Bone Joint J. 2014;96-B:759–64.CrossRefPubMed Tibrewal S, Malagelada F, Jeyaseelan L, Posch F, Scott G. Single-stage revision for the infected total knee replacement: results from a single centre. Bone Joint J. 2014;96-B:759–64.CrossRefPubMed
71.
go back to reference Labruyère C, Zeller V, Lhotellier L, Desplaces N, Léonard P, Mamoudy P, et al. Chronic infection of unicompartmental knee arthroplasty: one-stage conversion to total knee arthroplasty. Surg Res. 2015;101:553–7. Labruyère C, Zeller V, Lhotellier L, Desplaces N, Léonard P, Mamoudy P, et al. Chronic infection of unicompartmental knee arthroplasty: one-stage conversion to total knee arthroplasty. Surg Res. 2015;101:553–7.
72.
go back to reference •• George DA, Logoluso N, Castellini G, Gianola S, Scarponi S, Haddad FS, et al. Does cemented or cementless single-stage exchange arthroplasty of chronic periprosthetic hip infections provide similar infection rates to a two-stage? A systematic review. BMC Infect Dis. 2016;16:553. There was no statistically significant difference between a single-stage and a two-stage exchanges in terms of recurrence of infection in controlled studies (pooled odds ratio of 1.37 [95% CI = 0.68–2.74, I 2 = 45.5%]). Similarly, the recurrence infection rate in cementless versus cemented single-stage hip exchanges failed to demonstrate a significant difference, due to the substantial heterogeneity among the studies. No superiority was demonstrated between a single- and two-stage exchanges at a minimum of 12 months of follow-up in controlled studies. •• George DA, Logoluso N, Castellini G, Gianola S, Scarponi S, Haddad FS, et al. Does cemented or cementless single-stage exchange arthroplasty of chronic periprosthetic hip infections provide similar infection rates to a two-stage? A systematic review. BMC Infect Dis. 2016;16:553. There was no statistically significant difference between a single-stage and a two-stage exchanges in terms of recurrence of infection in controlled studies (pooled odds ratio of 1.37 [95% CI = 0.68–2.74, I 2= 45.5%]). Similarly, the recurrence infection rate in cementless versus cemented single-stage hip exchanges failed to demonstrate a significant difference, due to the substantial heterogeneity among the studies. No superiority was demonstrated between a single- and two-stage exchanges at a minimum of 12 months of follow-up in controlled studies.
73.
go back to reference Pattyn C, De Geest T, Ackerman P, Audenaert E. Preformed gentamicin spacers in two-stage revision hip arthroplasty: functional results and complications. Int. Orthop. Springer. 2011;35:1471–6.CrossRef Pattyn C, De Geest T, Ackerman P, Audenaert E. Preformed gentamicin spacers in two-stage revision hip arthroplasty: functional results and complications. Int. Orthop. Springer. 2011;35:1471–6.CrossRef
74.
go back to reference Faschingbauer M, Reichel H, Bieger R, Kappe T. Mechanical complications with one hundred and thirty eight (antibiotic-laden) cement spacers in the treatment of periprosthetic infection after total hip arthroplasty. Int Orthop. 2015;39:989–94.CrossRefPubMed Faschingbauer M, Reichel H, Bieger R, Kappe T. Mechanical complications with one hundred and thirty eight (antibiotic-laden) cement spacers in the treatment of periprosthetic infection after total hip arthroplasty. Int Orthop. 2015;39:989–94.CrossRefPubMed
75.
go back to reference • Fink B, Schlumberger M, Oremek D. Single-stage acetabular revision during two-stage THA revision for infection is effective in selected patients. Clin Orthop Relat Res 2017;475:2063–2070. Between June 2009 and June 2014, all patients underwent surgical treatment for an infected THA using a single-stage acetabular revision as part of a two-stage THA exchange if the acetabular defect classification was Paprosky types 2B, 2C, 3A, and 3B, or pelvic discontinuity, and a two-stage procedure was preferred for the femur. Thirty-four of 35 patients (97.2%; 95% CI, 85.4–99.5%) appeared free of infection at mean follow-up of 42 months. This technique is a promising treatment option for periprosthetic infections of the hip in which substantial acetabular defects exclude implantation of a normal spacer. • Fink B, Schlumberger M, Oremek D. Single-stage acetabular revision during two-stage THA revision for infection is effective in selected patients. Clin Orthop Relat Res 2017;475:2063–2070. Between June 2009 and June 2014, all patients underwent surgical treatment for an infected THA using a single-stage acetabular revision as part of a two-stage THA exchange if the acetabular defect classification was Paprosky types 2B, 2C, 3A, and 3B, or pelvic discontinuity, and a two-stage procedure was preferred for the femur. Thirty-four of 35 patients (97.2%; 95% CI, 85.4–99.5%) appeared free of infection at mean follow-up of 42 months. This technique is a promising treatment option for periprosthetic infections of the hip in which substantial acetabular defects exclude implantation of a normal spacer.
76.
go back to reference Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop Taylor Francis. 2009;80:193–7.CrossRef Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop Taylor Francis. 2009;80:193–7.CrossRef
77.
go back to reference Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;53:329–34.CrossRefPubMed Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;53:329–34.CrossRefPubMed
78.
go back to reference Stallmann HP, Faber C, Wuisman PIJM. Response to: release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;54:570–0. Stallmann HP, Faber C, Wuisman PIJM. Response to: release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;54:570–0.
79.
go back to reference Heesterbeek PJC, Wymenga AB, van Hellemondt GG. No difference in implant micromotion between hybrid fixation and fully cemented revision total knee arthroplasty. J Bone Jt Surg. 2016;98:1359–69.CrossRef Heesterbeek PJC, Wymenga AB, van Hellemondt GG. No difference in implant micromotion between hybrid fixation and fully cemented revision total knee arthroplasty. J Bone Jt Surg. 2016;98:1359–69.CrossRef
80.
go back to reference Ji B, Xu B, Guo W, Rehei A, Mu W, Yang D, et al. Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up. Int Orthop. 2017;41:901–9. Ji B, Xu B, Guo W, Rehei A, Mu W, Yang D, et al. Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up. Int Orthop. 2017;41:901–9.
81.
go back to reference Anagnostakos K, Kelm J, Schmitt E, Jung J. Fungal periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol. J Arthroplast. 2012;27:293–8.CrossRef Anagnostakos K, Kelm J, Schmitt E, Jung J. Fungal periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol. J Arthroplast. 2012;27:293–8.CrossRef
82.
go back to reference Ji B, Zhang X, Xu B, Guo W, Mu W. Single-stage revision for chronic fungal periprosthetic joint infection: an average of 5 years of follow-up. J Arthroplasty Elsevier Ltd. 2017;32:2523–30.CrossRef Ji B, Zhang X, Xu B, Guo W, Mu W. Single-stage revision for chronic fungal periprosthetic joint infection: an average of 5 years of follow-up. J Arthroplasty Elsevier Ltd. 2017;32:2523–30.CrossRef
83.
go back to reference Moore AJ, Blom AW, Whitehouse MR, Gooberman-Hill R. Managing uncertainty—a qualitative study of surgeons’ decision-making for one-stage and two-stage revision surgery for prosthetic hip joint infection. BMC Musculoskelet Disord. 2017;18:154.CrossRefPubMedPubMedCentral Moore AJ, Blom AW, Whitehouse MR, Gooberman-Hill R. Managing uncertainty—a qualitative study of surgeons’ decision-making for one-stage and two-stage revision surgery for prosthetic hip joint infection. BMC Musculoskelet Disord. 2017;18:154.CrossRefPubMedPubMedCentral
84.
go back to reference Masters JPM, Smith NA, Foguet P, Reed M, Parsons H, Sprowson AP. A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord. 2013;14:222.CrossRefPubMedPubMedCentral Masters JPM, Smith NA, Foguet P, Reed M, Parsons H, Sprowson AP. A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord. 2013;14:222.CrossRefPubMedPubMedCentral
85.
go back to reference Strange S, Whitehouse MR, Beswick AD, Board T, Burston A, Burston B. One-stage or two-stage revision surgery for prosthetic hip joint infection—the INFORM trial: a study protocol for a randomised controlled trial. Trials Trials. 2016;17:90.CrossRefPubMed Strange S, Whitehouse MR, Beswick AD, Board T, Burston A, Burston B. One-stage or two-stage revision surgery for prosthetic hip joint infection—the INFORM trial: a study protocol for a randomised controlled trial. Trials Trials. 2016;17:90.CrossRefPubMed
86.
go back to reference Gehrke T, Kendoff D. Peri-prosthetic hip infections: in favour of one-stage. Hip Int 22 Suppl. 8:S40–5. Gehrke T, Kendoff D. Peri-prosthetic hip infections: in favour of one-stage. Hip Int 22 Suppl. 8:S40–5.
Metadata
Title
The Role of One-Stage Exchange for Prosthetic Joint Infection
Authors
Fiachra E. Rowan
Matthew J. Donaldson
Jurek R. Pietrzak
Fares S. Haddad
Publication date
01-09-2018
Publisher
Springer US
Published in
Current Reviews in Musculoskeletal Medicine / Issue 3/2018
Electronic ISSN: 1935-9748
DOI
https://doi.org/10.1007/s12178-018-9499-7

Other articles of this Issue 3/2018

Current Reviews in Musculoskeletal Medicine 3/2018 Go to the issue

Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Intraoperative Considerations for Treatment/Prevention of Prosthetic Joint Infection

Foot and Ankle Trauma (G Moloney, section editor)

Limited Approaches to Calcaneal Fractures

Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection